Norinyl
(HFFGOURGAIOQBU-FOWHCLFSSA-N)
Structure
- SMILES
- C#C[C@]1(O)CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCC2=CC(=O)CC[C@H]12.C#C[C@]1(O)CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCc2c1ccc(c2)OC
- Molecular Formula:
- C41H52O4
- Molecular Weight:
- 608.849
- Log P:
- 7.4081
- Hydrogen Bond Acceptor:
- 4
- Hydrogen Bond Donor:
- 2
- TPSA:
- 66.76
- CAS Number(s):
- 8015-29-0
Synonym(s)
1.
Norinyl
2.
Norinyl 1-50
3.
Ortho Novum
4.
Ortho-Novum
5.
Orthonovin
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Abdominal Pain | FAERS: 3 | US FAERS | |
| 2 | Drug dose omission | FAERS: 3 | US FAERS | |
| 3 | Metrorrhagia | FAERS: 3 | US FAERS | |
| 4 | Nausea | FAERS: 3 | US FAERS | |
| 5 | Dehydration | FAERS: 2 | US FAERS | |
| 6 | Guillain-Barre Syndrome | FAERS: 2 | US FAERS | |
| 7 | Pulmonary Embolism | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 8 | Sjogren's Syndrome | FAERS: 2 | US FAERS | |
| 9 | Supraventricular tachycardia | FAERS: 2 | US FAERS | |
| 10 | Cerebral Thrombosis | FAERS: 1 | US FAERS | |
| 11 | Contraindicated product administered | FAERS: 1 | US FAERS | |
| 12 | Crying | FAERS: 1 | US FAERS | |
| 13 | Drug ineffective for unapproved indication | FAERS: 1 | US FAERS | |
| 14 | Endometriosis | FAERS: 1 | US FAERS | |
| 15 | Feeling abnormal | FAERS: 1 | US FAERS | |
| 16 | Headache | FAERS: 1 | US FAERS | |
| 17 | Hypotension | FAERS: 1 | US FAERS | |
| 18 | Irritable Bowel Syndrome | FAERS: 1 | US FAERS | |
| 19 | Menorrhagia | FAERS: 1 | US FAERS | |
| 20 | Mood swings | FAERS: 1 | US FAERS | |
| 21 | Osteoporosis | FAERS: 1 | US FAERS | |
| 22 | Palpitations | FAERS: 1 | US FAERS | |
| 23 | Polyuria | FAERS: 1 | US FAERS | |
| 24 | Post procedural complication | FAERS: 1 | US FAERS | |
| 25 | Pregnancy on oral contraceptive | FAERS: 1 | US FAERS | |
| 26 | Product dose omission | FAERS: 1 | US FAERS | |
| 27 | Product use in unapproved indication | FAERS: 1 | US FAERS | |
| 28 | Product use issue | FAERS: 1 | US FAERS | |
| 29 | Pulmonary congestion | FAERS: 1 | US FAERS | |
| 30 | Swelling | FAERS: 1 | US FAERS | |
| 31 | Asthenia | Canada Vigilance: 1 | Canada Vigilance | |
| 32 | Breast tenderness | Canada Vigilance: 1 | Canada Vigilance | |
| 33 | Cardiac Arrest | Canada Vigilance: 2 | Canada Vigilance | |
| 34 | Chest Pain | Canada Vigilance: 2 | Canada Vigilance | |
| 35 | Deep Vein Thrombosis | Canada Vigilance: 1 | Canada Vigilance | |
| 36 | Dermatitis | Canada Vigilance: 1 | Canada Vigilance | |
| 37 | Malaise | Canada Vigilance: 1 | Canada Vigilance | |
| 38 | Multiple Sclerosis | Canada Vigilance: 2 | Canada Vigilance | |
| 39 | Pneumonia | Canada Vigilance: 1 | Canada Vigilance | |
| 40 | Pulmonary thrombosis | Canada Vigilance: 1 | Canada Vigilance | |
| 41 | Thrombophlebitis | Canada Vigilance: 3 | Canada Vigilance | |
| 42 | Thrombosis | Canada Vigilance: 3 | Canada Vigilance | |
| 43 | Weight decreased | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.